P96 Repeat Administration of GL67A/pGM169 Is Feasible, Safe, and Produces Endogenous Levels of CFTR Expression After 12 Doses
Thorax - United Kingdom
doi 10.1136/thoraxjnl-2012-202678.338
Full Text
Open PDFAbstract
Available in full text
Date
November 19, 2012
Authors
Publisher
BMJ